| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |